Q1 2019 G1 Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to G1 First Quarter 2019 Corporate and Financial Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Mr. Jeff Macdonald, Head of Investor Relations. The floor is yours.
Thank you, operator. Good afternoon, everyone, and welcome to the G1 Therapeutics First Quarter 2019 Update. Joining me are Mark Velleca, Chief Executive Officer; and Raj Malik, Chief Medical Officer and Senior Vice President R&D. I'm also pleased to introduce Jen Moses, our Chief Financial Officer. John Demaree, our Chief Commercial Officer, will be available during the Q&A session.
Before we begin, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
